Life Sciences real estate transactions reached US$11b globally in the first half of 2021. What are the opportunities in Asia Pacific?

By Greg Hyland, Head of Capital Markets, Asia Pacific at CBRE, and Dr Henry Chin, Global Head of Investor Thought Leadership and Head of Research, Asia Pacific at CBRE

READ FULL ARTICLE